TCBP Stock Performance, Insider Transaction and News

TCBP - TC BioPharm (Holdings) plc

Market Cap	2.13M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-10.42M	Forward P/E	-0.54	EPS next Y	58.40%	50D Avg Chg	-43.00%
Sales	1.98M	PEG	-	EPS past 5Y	-	200D Avg Chg	-76.00%
Dividend	N/A	Price/Book	2.08	EPS next 5Y	-	52W High Chg	-97.00%
Recommedations	2.00	Quick Ratio	0.93	Shares Outstanding	794.95K	52W Low Chg	7.00%
Insider Own	36.62%	ROA	-76.27%	Shares Float	604.13K	Beta	-
Inst Own	21.73%	ROE	-	Shares Shorted/Prior	74.14K/67.86K	Price	2.68
Gross Margin	100.00%	Profit Margin	-	Avg. Volume	1,235,649	Target Price	9.00
Oper. Margin	-626.83%	Earnings Date	-	Volume	48,515	Change	-7.90%

Healthcare | Biotechnology | United Kingdom

About TC BioPharm (Holdings) plc

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TC BioPharm (Holdings) plc News

03/22/23	TC Biopharm Announces Corporate Restructuring, Reduction in Overhead
03/16/23	TC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2)
03/07/23	TC BioPharm Shifts Focus to FDA Clinical Trials
08:30 AM	TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer
02/21/23	TC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies
02/14/23	TC BioPharm Announces New Chair of the Board, Arlene Morris
02/13/23	TC BioPharm to Reschedule Shareholder Update Call and Webcast
02/07/23	TC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety Cohort
01/30/23	TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
01/20/23	TC BioPharm to Host Shareholder Update Call
01/19/23	TC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)
01/17/23	TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
12/12/22	TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update
11/30/22	TC BioPharm Announces Closing of $7.35 Million Private Placement
11/28/22	TC BioPharm Announces $7.35 Million Private Placement
11/22/22	TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia
11/21/22	TC Biopharm (Holdings) Plc's (NASDAQ:TCBP) biggest owners are individual investors who got richer after stock soared 11% last week
10/26/22	TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise
10/03/22	TC BioPharm to Present at Upcoming Investor Conferences
09/13/22	TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune®

TCBP Chatroom

donotfollowFoff Posted - 4 minutes ago

$TCBP junk

iPipediCarly Posted - 31 minutes ago

$TCBP I've been watching this since the start of the new year and the amount of fuckery this stock does is wilder than a season of jersey shore. When there's a lot of weird shit going on though, that's usually a sign a pump is among us

mmushonga Posted - 43 minutes ago

$TCBP Im shiting bricks here, folks. I was all in. Have we been played?

Stocktelligence Posted - 57 minutes ago

$TCBP

Insider666 Posted - 1 hour ago

$TCBP It is a scam!!!

AshleySchaeffer_BMW Posted - 1 hour ago

@SparkySC 5 years out 5$ strike, Feb 28 expiry $TCBP

M1Tanker Posted - 1 hour ago

$TCBP pfft

AshleySchaeffer_BMW Posted - 2 hours ago

$TCBP added all the warrants today, 7s are a steal!!

eTXtrd1 Posted - 2 hours ago

$TCBP where’s all the “beaten down, oversold, undervalued” pumpers?!? Come do your thing! 🤪😂

DinamoZagreb007 Posted - 2 hours ago

$TCBP

Fishbanger51 Posted - 2 hours ago

$TCBP time to dollar cost average

Fletcherxonly Posted - 2 hours ago

$TCBP why the drop? Was thinking about jumping in..

allgoodstill Posted - 2 hours ago

$TCBP From $5 to .05.

NokiaYOLOCalls Posted - 2 hours ago

$TCBP No way😐

Market_Magician Posted - 2 hours ago

$TCBP only solace here is that it is on super low volume.

Endalykt Posted - 2 hours ago

$TCBP WTF

Hkelly Posted - 2 hours ago

$TCBP can’t believe, nobody want to buy 😅

Djinn88 Posted - 2 hours ago

$TCBP Such a POS. Down on green and even more on red days 🤣🤣🤣🤣

Market_Magician Posted - 2 hours ago

$TCBP this POS is done.

ShadedThorn Posted - 2 hours ago

$TCBP are you fucking kidding me

staywild Posted - 2 hours ago

$TCBP can only imagine this will go down until of q1 before reversing unless they send it next week to end q1 on a high note

Fishbanger51 Posted - 2 hours ago

$TCBP 52 week low

Endalykt Posted - 3 hours ago

$TCBP shitshow🤮

NokiaYOLOCalls Posted - 3 hours ago

$TCBP

Kelly12 Posted - 3 hours ago

$TCBP prefer companies that have big Pharma ownership ….. any suggestions? This is dead money for now?

RB26LOVER Posted - 3 hours ago

$TCBP can I have some at 2.50 please !!!

Moraldole Posted - 4 hours ago

$TCBP how low can she go? 🙄

PennyStockGod1 Posted - 5 hours ago

$PMEDF PR OUT!!! This thing is gonna explode… So undervalued and not found yet… AI play with only 7.6mil float currently trading at .10 😱 $PIXY $WISA $TCBP $HUBC

risenhoover Posted - 6 hours ago

$TCBP TCBP / TC BioPharm (Holdings) Ltd Price Target Updated https://fintel.io/sfo/us/tcbp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

ChartMill Posted - 10 hours ago

$TCBP is expected to show a strong revenue growth of 2786.48% yearly. https://www.chartmill.com/stock/quote/TCBP/fundamental-analysis?key=d61d7701-b02a-4522-ab56-8262512d7c7c&utm_source=stocktwits&utm_medium=FA&utm_content=TCBP&utm_campaign=social_tracking

Analyst Ratings

HC Wainwright & Co.	Buy	Jan 26, 23
EF Hutton	Buy	Mar 28, 22

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Randall Mark Edward	10% Owner 10% Owner	Nov 30	Buy	5	70,000	350,000	382,963	01/11/23
Randall Kenneth Edward	10% Owner 10% Owner	Nov 30	Buy	5	70,000	350,000	382,963	01/11/23
Renaissance Capital Partners L...	10% Owner 10% Owner	Nov 30	Buy	5	70,000	350,000	136,834	01/11/23
Randall Kenneth Edward	10% Owner 10% Owner	May 24	Buy	1.15	20,803	23,923	100,418	07/14/22